Grant: Discovery Grants Program - Individual
University of British Columbia
$24,000.00
The genetics of altitude acclimatisation in humans
EF 2012-13
Résumé
The capacity to acclimatise to hypoxia varies at both the individual and the population level. One of my central research goals is to understand the extent to which, and by what mechanisms, genetic background contributes to this variation. The model we use is acute mountain sickness (AMS), which is a manifestation of inadequate or delayed altitude acclimatisation. Our objectives for the next five years are fourfold:
1) We will continue to collect DNAs from individuals with and without AMS at the annual Janai Purnima Festival in Nepal (4380 m) for use in our ongoing candidate gene association studies.
2) We will undertake the first genome-wide association study (GWAS) of AMS susceptibility. Using a DNA 'chip', over 900000 genetic variants will be tested in a subset of our AMS+/- DNA collection. Variants that associate with AMS and are in/near genes that encode proteins in pathways related to the hypoxia response or that could contribute to the aetiology of AMS will be then tested in the entire DNA bank.
3) While there is much interest in the role of genetics in altitude acclimatisation and AMS, there are few studies on familial patterns of variation in the short-term hypoxia response. We will expose twin pairs (mono- and dizygotic) to simulated altitude (13% O2) in our hypoxia chamber at UBC. Concordance between co-twins and heritabilities for 1) AMS (susceptibility and/or severity) and 2) various physiological responses will be determined. We hypothesize that there will be a genetic component to the hypoxia response and AMS, which will manifest as greater concordance between the monozygotic co-twins compared to dizygotic pairs.
4) The Nepalese population is mostly a mix of people of either Indian or Tibetan origins. We predict that the latter will be less susceptible to AMS as there is substantial evidence that Tibetans are evolutionarily adapted to altitude. We will test this hypothesis using ancestry-informative genetic markers.
OVERALL, these interrelated and synergistic studies will provide insights into the genetic and physiological bases of successful altitude adaptation and its antithesis, susceptibility to altitude-related illnesses.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
312250-2011
Name nom
Rupert, Jim
Department département
Human Kinetics, School of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5502
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Kinesiology
Research subject fr
Kinésiologie
Partie
2
Nb partie
5
Application title
The genetics of altitude acclimatisation in humans
Keyword
NSERC
Application summary
The capacity to acclimatise to hypoxia varies at both the individual and the population level. One of my central research goals is to understand the extent to which, and by what mechanisms, genetic background contributes to this variation. The model we use is acute mountain sickness (AMS), which is a manifestation of inadequate or delayed altitude acclimatisation. Our objectives for the next five years are fourfold:
1) We will continue to collect DNAs from individuals with and without AMS at the annual Janai Purnima Festival in Nepal (4380 m) for use in our ongoing candidate gene association studies.
2) We will undertake the first genome-wide association study (GWAS) of AMS susceptibility. Using a DNA 'chip', over 900000 genetic variants will be tested in a subset of our AMS+/- DNA collection. Variants that associate with AMS and are in/near genes that encode proteins in pathways related to the hypoxia response or that could contribute to the aetiology of AMS will be then tested in the entire DNA bank.
3) While there is much interest in the role of genetics in altitude acclimatisation and AMS, there are few studies on familial patterns of variation in the short-term hypoxia response. We will expose twin pairs (mono- and dizygotic) to simulated altitude (13% O2) in our hypoxia chamber at UBC. Concordance between co-twins and heritabilities for 1) AMS (susceptibility and/or severity) and 2) various physiological responses will be determined. We hypothesize that there will be a genetic component to the hypoxia response and AMS, which will manifest as greater concordance between the monozygotic co-twins compared to dizygotic pairs.
4) The Nepalese population is mostly a mix of people of either Indian or Tibetan origins. We predict that the latter will be less susceptible to AMS as there is substantial evidence that Tibetans are evolutionarily adapted to altitude. We will test this hypothesis using ancestry-informative genetic markers.
OVERALL, these interrelated and synergistic studies will provide insights into the genetic and physiological bases of successful altitude adaptation and its antithesis, susceptibility to altitude-related illnesses.